# Board of Radiation and Isotope Technology

Source: https://nuclide.cc/institutions/brit/  
Nuclide record `brit` (Institution). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

India's government isotope producer: it makes and sells the radioactive medicines used in Indian hospitals.

## Summary

BRIT is a unit of India's Department of Atomic Energy and the country's main supplier of radiopharmaceuticals. Its own therapeutic product page lists sodium iodide I-131, I-131 mIBG, lutetium-177 EDTMP, lutetium-177 DOTATATE and lutetium-177 PSMA-617 injection in production - which means India manufactures domestically the same PSMA radioligand therapy that is sold in the West as Pluvicto, at a scale set by public supply rather than by a marketing authorisation.

The practical constraint is feedstock: India is not self-sufficient in molybdenum-99 or iodine-131, so hospital supply depends on reactor availability and imports. BRIT's site is intermittently unreachable from outside India, so the product list above was read in a browser session on 22 September 2026 rather than by an automated fetch, and the regulator route (CDSCO's approved-new-drugs PDFs) blocks scripts entirely.

## Fields

- Kind: Institution
- Last checked: 2026-09-22
- Also known as: BRIT
- City: Navi Mumbai, IN
- Type: government
- Website: https://britatom.gov.in/

## Sources

- BRIT therapeutic radiopharmaceuticals product list: https://britatom.gov.in/en/product/radiopharmaceuticals/therapeutic
- BRIT (Department of Atomic Energy): https://britatom.gov.in/

## Connected records

- isotopes: [Iodine-131](https://nuclide.cc/isotopes/i-131/), [Lutetium-177](https://nuclide.cc/isotopes/lu-177/), [Molybdenum-99](https://nuclide.cc/isotopes/mo-99/)
- drugs: [Radioactive iodine (I-131)](https://nuclide.cc/drugs/radioactive-iodine/)
- institutions: [All India Institute of Medical Sciences, New Delhi](https://nuclide.cc/institutions/aiims-delhi/)

---
JSON: https://nuclide.cc/api/v1/entities/brit.json